178 related articles for article (PubMed ID: 34286631)
1. Tumor RNA-loaded nanoliposomes increases the anti-tumor immune response in colorectal cancer.
Dai D; Yin Y; Hu Y; Lu Y; Zou H; Lu G; Wang Q; Lian J; Gao J; Shen X
Drug Deliv; 2021 Dec; 28(1):1548-1561. PubMed ID: 34286631
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of Tumor RNA-Loaded Lipid Nanoparticles Against Hepatocellular Carcinoma.
Zhang Y; Xie F; Yin Y; Zhang Q; Jin H; Wu Y; Pang L; Li J; Gao J
Int J Nanomedicine; 2021; 16():1553-1564. PubMed ID: 33658783
[TBL] [Abstract][Full Text] [Related]
3. Novel hyaluronic acid oligosaccharide-loaded and CD44v6-targeting oxaliplatin nanoparticles for the treatment of colorectal cancer.
Du W; Yang X; He S; Wang J; Guo Y; Kou B; Jiang Y; Bian P; Li B; Yin L
Drug Deliv; 2021 Dec; 28(1):920-929. PubMed ID: 33974471
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic Acid Capped, Irinotecan and Gene Co-Loaded Lipid-Polymer Hybrid Nanocarrier-Based Combination Therapy Platform for Colorectal Cancer.
Wang Z; Zang A; Wei Y; An L; Hong D; Shi Y; Zhang J; Su S; Fang G
Drug Des Devel Ther; 2020; 14():1095-1105. PubMed ID: 32210538
[TBL] [Abstract][Full Text] [Related]
5. A novel method for the development of plasmid DNA-loaded nanoliposomes for cancer gene therapy.
Baradaran B; Mohammadi A; Shamekhi S; Majidazar N; Dilmaghani A; Soofiyani SR; McMillan NA; Lotfipour F; Hallaj-Nezhadi S
Drug Deliv Transl Res; 2022 Jun; 12(6):1508-1520. PubMed ID: 34322851
[TBL] [Abstract][Full Text] [Related]
6. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
Shaji J; Menon I
Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
[TBL] [Abstract][Full Text] [Related]
7. Sequential treatment of oxaliplatin-containing PEGylated liposome together with S-1 improves intratumor distribution of subsequent doses of oxaliplatin-containing PEGylated liposome.
Nakamura H; Doi Y; Abu Lila AS; Nagao A; Ishida T; Kiwada H
Eur J Pharm Biopharm; 2014 May; 87(1):142-51. PubMed ID: 24361534
[TBL] [Abstract][Full Text] [Related]
8. QbD Enabled Development and Evaluation of Pazopanib Loaded Nanoliposomes for PDAC Treatment.
Shinde A; Panchal K; Patra P; Singh S; Enakolla S; Paliwal R; Chaurasiya A
AAPS PharmSciTech; 2024 May; 25(5):97. PubMed ID: 38710894
[TBL] [Abstract][Full Text] [Related]
9. Bioactive Peptides Sensitize Cells to Anticancer Effects of Oxaliplatin in Human Colorectal Cancer Xenografts in Nude Mice.
Li X; Xia L; Ouyang X; Suyila Q; Su L; Su X
Protein Pept Lett; 2019; 26(7):512-522. PubMed ID: 30950338
[TBL] [Abstract][Full Text] [Related]
10. Stimulation of Tumor-Specific Immunity by p5 HER-2/neu Generated Peptide Encapsulated in Nano-liposomes with High Phase Transition Temperature Phospholipids.
Yazdani M; Jalali SA; Badiee A; Shariat S; Mansourian M; Arabi L; Abbasi A; Saberi Z; Jaafari MR
Curr Drug Deliv; 2017; 14(4):492-502. PubMed ID: 27411392
[TBL] [Abstract][Full Text] [Related]
11. Improved anti-colorectal carcinomatosis effect of tannic acid co-loaded with oxaliplatin in nanoparticles encapsulated in thermosensitive hydrogel.
Ren Y; Li X; Han B; Zhao N; Mu M; Wang C; Du Y; Wang Y; Tong A; Liu Y; Zhou L; You C; Guo G
Eur J Pharm Sci; 2019 Feb; 128():279-289. PubMed ID: 30553061
[TBL] [Abstract][Full Text] [Related]
12. Characterization of PEGylated nanoliposomes co-remotely loaded with topotecan and vincristine: relating structure and pharmacokinetics to therapeutic efficacy.
Zucker D; Andriyanov AV; Steiner A; Raviv U; Barenholz Y
J Control Release; 2012 Jun; 160(2):281-9. PubMed ID: 22019556
[TBL] [Abstract][Full Text] [Related]
13. Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.
Zhang Z; Qian H; Huang J; Sha H; Zhang H; Yu L; Liu B; Hua D; Qian X
Int J Nanomedicine; 2018; 13():4961-4975. PubMed ID: 30214200
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of oxaliplatin and irinotecan co-loaded liposomes for enhanced colorectal cancer therapy.
Zhang B; Wang T; Yang S; Xiao Y; Song Y; Zhang N; Garg S
J Control Release; 2016 Sep; 238():10-21. PubMed ID: 27432750
[TBL] [Abstract][Full Text] [Related]
15. Nanoliposome-loaded phenolics from Salvia leriifolia Benth and its anticancer effects against induced colorectal cancer in mice.
Nasrabadi NS; Vedad A; Asadi K; Poorbagher MRM; Tabrizi NA; Dorooki K; Sabouni RS; Moghadam MB; Shafaei N; Karimi E; Oskoueian E
Biotechnol Appl Biochem; 2024 Jun; 71(3):641-650. PubMed ID: 38326022
[TBL] [Abstract][Full Text] [Related]
16. Transferrin receptors targeting peptide (T7 peptide) surface-modified sorafenib nanoliposomes enhance the anti-tumor effect in colorectal cancer.
Wang S; Sun H
Pharm Dev Technol; 2020 Nov; 25(9):1063-1070. PubMed ID: 32589499
[TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization and in vitro efficacy of magnetic nanoliposomes containing the artemisinin and transferrin.
Gharib A; Faezizadeh Z; Mesbah-Namin SA; Saravani R
Daru; 2014 May; 22(1):44. PubMed ID: 24887240
[TBL] [Abstract][Full Text] [Related]
18. Thymol-loaded liposomes effectively induced apoptosis and decreased EGFR expression in colorectal cancer cells.
Keshavarz F; Soltanshahi M; Khosravani F; Bakhshiyan F; Ghanbari A; Hassanzadeh S; Amirpour M; Ghalamfarsa G
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):5157-5165. PubMed ID: 38240780
[TBL] [Abstract][Full Text] [Related]
19. Decreasing acute toxicity and suppressing colorectal carcinoma using Sorafenib-loaded nanoparticles.
Li N; Chen Y; Sun H; Huang T; Chen T; Jiang Y; Yang Q; Yan X; Wu M
Pharm Dev Technol; 2020 Jun; 25(5):556-565. PubMed ID: 31958240
[No Abstract] [Full Text] [Related]
20. Development of a novel liposomal nanoparticle formulation of cisplatin to breast cancer therapy.
Ghafari M; Haghiralsadat F; Khanamani Falahati-Pour S; Zavar Reza J
J Cell Biochem; 2020 Jul; 121(7):3584-3592. PubMed ID: 31907989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
